Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Comment by Stocktreeon Feb 05, 2016 3:10pm
130 Views
Post# 24529686

RE:RE:Fun with math

RE:RE:Fun with mathWhat would be great is if the whole truth would be revealed at once, but at least, when a company states figures, we would appreciate if they were somewhat accurate. The number of cases in the US can absolutely not be half the number of cases in the world for this type of condition.

Good thing to point out there, MM.

As for Daviking,

Why would we suppose the company is speaking of the number of "cases they will be called to treat" when they say "sepsis cases in the US"? If we want to come up with the nbr of PMX treated cases, we will want to substract from some accurate figure first, not from one that is based on an inexact definition of "number of cases". We should always be watchful for misleading statements, whether they seem too optimistic or the opposite.

It is scary enough that we are dealing with an imperfect human entity (FDA). Let's not cloud the issue with careless stats an opinions. In information, bias is not good. Unfavorable of favorable.

Bullboard Posts